MAIA Biotechnology, Inc. Establishes Wholly Owned Subsidiaries in Romania and Australia to Support Global Development of THIO
-Expanded clinical development presence is expected to accelerate activities for THIO-101 Phase 2 Trial for NSCLC- CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc.,...









